TC BioPharm (Holdings) PLC (TCBP)
0.6936
+0.04
(+6.90%)
USD |
NASDAQ |
Nov 15, 09:56
TC BioPharm Cash and Short Term Investments (Quarterly): 1.238M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.238M |
| June 30, 2023 | 2.420M |
| December 31, 2022 | 5.819M |
| June 30, 2022 | 7.274M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.114M |
| September 30, 2021 | 2.082M |
| December 31, 2020 | 1.019M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.019M
Minimum
Dec 2020
7.274M
Maximum
Jun 2022
3.138M
Average
2.114M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 214.79M |
| Biodexa Pharmaceuticals PLC | 6.394M |
| Verona Pharma PLC | 336.04M |
| NuCana PLC | 14.72M |
| Autolus Therapeutics PLC | 705.94M |